Xencor Inc (14) | License Agreements (3)
Recent Contracts
-
First Amendment to the Research and License Agreement, dated November 22, 2019, by and between the Company and Amgen Inc
(Filed With SEC on February 24, 2021)
-
Second Amendment to the License Agreement, dated January 8, 2020, by and between the Company and MorphoSys AG
(Filed With SEC on February 24, 2021)
-
Third Amendment to the License Agreement, dated July 13, 2020, by and between the Company and MorphoSys AG
(Filed With SEC on February 24, 2021)